Outcome of patients with fortuitous prostate cancer after radical cystoprostatectomy for bladder cancer

被引:37
作者
Delongchamps, NB [1 ]
Mao, K [1 ]
Theng, H [1 ]
Zerbib, M [1 ]
Debré, B [1 ]
Peyromaure, M [1 ]
机构
[1] Cochin Hosp, Serv Urol, Dept Urol, F-75014 Paris, France
关键词
prostate cancer; bladder tumour; cystoprostatectomy; diagnosis;
D O I
10.1016/j.eururo.2005.07.008
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objectives: To analyze the outcome of patients after fortuitous diagnosis of prostate cancer (PCa) on cystoprostatectomy (CPT) specimen. Methods: The medical charts of 141 male patients who underwent radical CPT for urothelial cell carcinoma of the bladder between january 1995 and april 2000 were retrospectively reviewed. None of the patients had preoperative clinical or biological suspicion of PCa. Results: Pathological examination of the CPT specimens showed PCa in 20 patients (14.2%). Of these, 6 had a microfocal PCa, 10 had a pT2a tumour, 2 had a pT2b tumour, and 2 had a pT3a tumour. The Gleason score was <= 5 in 5 cases, 6 in 13 cases, and 7 in 2 cases. Two patients were lost to follow-up. Ten patients died of bladder cancer after a median follow-up of 13 months. Eight patients remained free of disease after a median follow-up of 64.5 months. None of the 20 patients experienced PCa recurrence during follow-up. Conclusions: In our experience, the rate of unsuspected PCa on cystoprostatectomy specimens was 14.2%. The majority of these PCas were organ-confined, and there was no PCa recurrence during follow-up. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:946 / 950
页数:5
相关论文
共 23 条
[1]  
Abbas A, 1996, EUR UROL, V30, P322
[2]  
Amara N, 2001, CANCER RES, V61, P4660
[3]   COINCIDENT VESICAL TRANSITIONAL CELL-CARCINOMA AND PROSTATIC-CARCINOMA - CLINICAL-FEATURES AND TREATMENT [J].
ANDROULAKAKIS, PA ;
SCHNEIDER, HM ;
JACOBI, GH ;
HOHENFELLNER, R .
BRITISH JOURNAL OF UROLOGY, 1986, 58 (02) :153-156
[4]   Prostatic capsule- and seminal-sparing cystectomy for bladder carcinoma: initial results for selected patients [J].
Botto, H ;
Sebe, P ;
Molinie, V ;
Herve, JM ;
Yonneau, L ;
Lebret, T .
BJU INTERNATIONAL, 2004, 94 (07) :1021-1025
[5]   Coincidence of bladder and prostate cancer [J].
Chun, TY .
JOURNAL OF UROLOGY, 1997, 157 (01) :65-67
[6]   Recent trends in prostate cancer incidence and mortality in Southeast England [J].
Evans, HS ;
Moller, H .
EUROPEAN UROLOGY, 2003, 43 (04) :337-341
[7]   LATENT PROSTATIC-CANCER IN A CONSECUTIVE AUTOPSY SERIES [J].
HOLUND, B .
SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 1980, 14 (01) :29-35
[8]   UNSUSPECTED ADENOCARCINOMA OF THE PROSTATE IN PATIENTS UNDERGOING CYSTOPROSTATECTOMY FOR OTHER CAUSES - INCIDENCE, HISTOLOGY AND MORPHOMETRIC OBSERVATIONS [J].
KABALIN, JN ;
MCNEAL, JE ;
PRICE, HM ;
FREIHA, FS ;
STAMEY, TA .
JOURNAL OF UROLOGY, 1989, 141 (05) :1091-1094
[9]   SIMULTANEOUS PRESENTATION OF ADENOCARCINOMA OF PROSTATE AND TRANSITIONAL CELL-CARCINOMA OF BLADDER [J].
KONSKI, A ;
RUBIN, P ;
DISANTANGNESE, PA ;
MAYER, E ;
KEYS, H ;
COCKETT, A ;
FRANK, I ;
DAVIS, R ;
LUSH, C .
UROLOGY, 1991, 37 (03) :202-206
[10]   Comparative study on the prevalence of clinically detectable prostate cancer in patients with and without bladder cancer [J].
Kurokawa, K ;
Ito, K ;
Yamamoto, T ;
Takechi, H ;
Miyamoto, S ;
Suzuki, K ;
Yamanaka, H .
UROLOGY, 2004, 63 (02) :268-272